Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Relationship between metabolic and vascular conditions and cognitive decline among older Mexican Americans.

Downer B, Raji MA, Markides KS.

Int J Geriatr Psychiatry. 2016 Mar;31(3):213-21. doi: 10.1002/gps.4313. Epub 2015 May 29.

2.

Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers.

Zhong G, Wang Y, Zhang Y, Guo JJ, Zhao Y.

PLoS One. 2015 Mar 12;10(3):e0118333. doi: 10.1371/journal.pone.0118333. eCollection 2015. Review. Erratum in: PLoS One. 2015;10(4):e0126169.

3.

Smoking and increased Alzheimer's disease risk: a review of potential mechanisms.

Durazzo TC, Mattsson N, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2014 Jun;10(3 Suppl):S122-45. doi: 10.1016/j.jalz.2014.04.009. Review.

4.

EVALUATION OF HOW CIGARETTE SMOKE IS A DIRECT RISK FACTOR FOR ALZHEIMER'S DISEASE.

Giunta B, Deng J, Jin J, Sadic E, Rum S, Zhou H, Sanberg P, Tan J.

Technol Innov. 2012 Jan 1;14(1):39-48.

5.

Type 2 diabetes and ethnic disparities in cognitive impairment.

Noble JM, Manly JJ, Schupf N, Tang MX, Luchsinger JA.

Ethn Dis. 2012 Winter;22(1):38-44.

6.

The nicotinic acetylcholine receptor: smoking and Alzheimer's disease revisited.

Mehta M, Adem A, Kahlon MS, Sabbagh MN.

Front Biosci (Elite Ed). 2012 Jan 1;4:169-80. Review.

7.

Effect of Apolipoprotein E epsilon4 on the association between health behaviors and cognitive function in late midlife.

Sabia S, Kivimaki M, Kumari M, Shipley MJ, Singh-Manoux A.

Mol Neurodegener. 2010 Jun 1;5:23. doi: 10.1186/1750-1326-5-23.

8.

Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation.

Cataldo JK, Prochaska JJ, Glantz SA.

J Alzheimers Dis. 2010;19(2):465-80. doi: 10.3233/JAD-2010-1240.

9.

Role of vascular risk factors and vascular dysfunction in Alzheimer's disease.

Dickstein DL, Walsh J, Brautigam H, Stockton SD Jr, Gandy S, Hof PR.

Mt Sinai J Med. 2010 Jan-Feb;77(1):82-102. doi: 10.1002/msj.20155. Review.

10.

Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention.

Qiu C, Kivipelto M, von Strauss E.

Dialogues Clin Neurosci. 2009;11(2):111-28. Review.

11.

Anti-inflammatory and immune therapy for Alzheimer's disease: current status and future directions.

Walker D, Lue LF.

Curr Neuropharmacol. 2007 Dec;5(4):232-43. doi: 10.2174/157015907782793667.

12.

Smoking, dementia and cognitive decline in the elderly, a systematic review.

Peters R, Poulter R, Warner J, Beckett N, Burch L, Bulpitt C.

BMC Geriatr. 2008 Dec 23;8:36. doi: 10.1186/1471-2318-8-36. Review.

13.

L-arginine and Alzheimer's disease.

Yi J, Horky LL, Friedlich AL, Shi Y, Rogers JT, Huang X.

Int J Clin Exp Pathol. 2009;2(3):211-38. Epub 2008 Oct 2.

14.

Cardiovascular risk factors and incident Alzheimer disease: a systematic review of the literature.

Purnell C, Gao S, Callahan CM, Hendrie HC.

Alzheimer Dis Assoc Disord. 2009 Jan-Mar;23(1):1-10. doi: 10.1097/WAD.0b013e318187541c. Review.

Supplemental Content

Support Center